Mami Sato
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
-
- Ferroptosis and cancer prognosis
Papers in
-
- Protease and Inhibitor Mechanisms 3
- Oncology 7
- Peptidase Inhibition and Analysis 3
- Co-authors
- Hideyo Sato (5 shared papers)Marcus Conrad (4 shared papers)Shiro Bannai (4 shared papers)Sho Kobayashi (3 shared papers)Ryosuke Kusumi (3 shared papers)Yuhei Komiyama (1 shared paper)T. Izumikawa (1 shared paper)Satoru Sasaki (1 shared paper)
- Journals
- Experimental Cell Research (2 papers)Journal of Biological Chemistry (2 papers)Cell Death and Disease (2 papers)Blood Purification (1 paper)SpringerPlus (1 paper)
- Partner nations
- JapanGermanyUnited States
In The Last Decade
Mami Sato
29 papers receiving 1.5k citations
Mami Sato's Hit Papers
Peers
Comparison fields: 5 of 113
- Cancer Research 391
- Pulmonary and Respiratory Medicine 518
- Immunology and Allergy 81
- Molecular Biology 664
- Biochemistry 69
Countries citing papers authored by Mami Sato
This map shows the geographic impact of Mami Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mami Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mami Sato more than expected).
Fields of papers citing papers by Mami Sato
This network shows the impact of papers produced by Mami Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mami Sato. The network helps show where Mami Sato may publish in the future.
Co-authors
The 25 scholars most cited alongside Mami Sato, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The ferroptosis inducer erastin irreversibly inhibits system xc− and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells Hit paper breakdown → | 2018 | 336 |
| 2 | 2021 | 160 | |
| 3 | 2020 | 117 | |
| 4 | 2012 | 106 | |
| 5 | 2004 | 101 | |
| 6 | 2011 | 90 | |
| 7 | 2015 | 77 | |
| 8 | 2020 | 55 | |
| 9 | 2007 | 51 | |
| 10 | 2013 | 47 | |
| 11 | 2018 | 46 | |
| 12 | 2014 | 35 | |
| 13 | 2019 | 33 | |
| 14 | 2017 | 32 | |
| 15 | 2011 | 29 | |
| 16 | 2020 | 29 | |
| 17 | 2004 | 29 | |
| 18 | 2018 | 29 | |
| 19 | 2015 | 28 | |
| 20 | 2014 | 23 |
About Mami Sato
Mami Sato is a scholar working on Cancer Research, Oncology, Immunology and Allergy, Biochemistry and Pathology and Forensic Medicine, having authored 29 papers that have together received 1.5k indexed citations. Recurring topics across this work include Amino Acid Enzymes and Metabolism (3 papers), Protease and Inhibitor Mechanisms (3 papers), Ferroptosis and cancer prognosis (3 papers), Peptidase Inhibition and Analysis (3 papers), Cell Adhesion Molecules Research (3 papers), Dialysis and Renal Disease Management (2 papers), Sulfur Compounds in Biology (2 papers) and Breast Lesions and Carcinomas (2 papers). The work is most often cited by research in Cancer Research (391 citations), Pulmonary and Respiratory Medicine (518 citations), Immunology and Allergy (81 citations), Molecular Biology (664 citations) and Biochemistry (69 citations). Mami Sato has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Hideyo Sato, Marcus Conrad, Shiro Bannai, Sho Kobayashi, Ryosuke Kusumi, Yuhei Komiyama, T. Izumikawa, Satoru Sasaki, Bettina Proneth and Eikan Mishima. Their work appears in journals such as Experimental Cell Research, Journal of Biological Chemistry, Cell Death and Disease, Blood Purification and SpringerPlus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.